Cargando…
EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjögren’s Syndrome
OBJECTIVES: Enhancer of zeste homolog 2 (EZH2) is an epigenetic regulator that plays an essential role in immune system development and autoimmune diseases. This study aimed to characterize the role of EZH2 in the pathogenesis of primary Sjögren’s syndrome (pSS). METHODS: We analyzed EZH2 expression...
Autores principales: | He, Chengmei, Yang, Yanlei, Chen, Zhilei, Liu, Suying, Lyu, Taibiao, Zeng, Liuting, Wang, Li, Li, Yongzhe, Wang, Mu, Chen, Hua, Zhang, Fengchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252457/ https://www.ncbi.nlm.nih.gov/pubmed/35795677 http://dx.doi.org/10.3389/fimmu.2022.922871 |
Ejemplares similares
-
Long Non-coding RNA Regulation of Mesenchymal Stem Cell Homeostasis and Differentiation: Advances, Challenges, and Perspectives
por: Yang, Yanlei, et al.
Publicado: (2021) -
Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling
por: Lyu, Taibiao, et al.
Publicado: (2023) -
LncRNA LYPLAL1-AS1 rejuvenates human adipose-derived mesenchymal stem cell senescence via transcriptional MIRLET7B inactivation
por: Yang, Yanlei, et al.
Publicado: (2022) -
Ten-year survival analysis of patients with primary Sjögren’s
syndrome in China: a national prospective cohort study
por: Qian, Junyan, et al.
Publicado: (2021) -
Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges
por: He, Chengmei, et al.
Publicado: (2021)